92 related articles for article (PubMed ID: 2758565)
21. [Clinical pharmacology of a oxazaphosphorine derivative--ifosfamide].
Matusewicz W; Robak T
Pol Tyg Lek; 1991 Aug 5-19; 46(32-34):621-4. PubMed ID: 1669128
[No Abstract] [Full Text] [Related]
22. The use of ifosfamide, carboplatin, and etoposide in children with solid tumors.
Cairo MS
Semin Oncol; 1995 Jun; 22(3 Suppl 7):23-7. PubMed ID: 7610395
[TBL] [Abstract][Full Text] [Related]
23. Ifosfamide in the treatment of pediatric malignancies.
Voûte PA; van den Berg H; Behrendt H; Michiels E; de Kraker J
Semin Oncol; 1996 Jun; 23(3 Suppl 7):8-11. PubMed ID: 8711502
[TBL] [Abstract][Full Text] [Related]
24. Introducing ifosfamide in innovative treatment modalities.
Dittrich C
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S1-3. PubMed ID: 12042981
[No Abstract] [Full Text] [Related]
25. Recent advances in cancer chemotherapy. Proceedings of a symposium of the 5th European Conference on Clinical Oncology. September 3, 1989, London.
Semin Oncol; 1990 Feb; 17(1 Suppl 2):1-74. PubMed ID: 2305268
[No Abstract] [Full Text] [Related]
26. Phase II trial of ifosfamide in children with malignant solid tumors.
Pratt CB; Horowitz ME; Meyer WH; Etcubanas E; Thompson EI; Douglass EC; Wilimas JA; Hayes FA; Green AA
Cancer Treat Rep; 1987 Feb; 71(2):131-5. PubMed ID: 3100034
[TBL] [Abstract][Full Text] [Related]
27. Ifosfamide-induced neurotoxicity: associated symptoms and nursing implications.
Cain JW; Bender CM
Oncol Nurs Forum; 1995 May; 22(4):659-66; quiz 667-8. PubMed ID: 7675668
[TBL] [Abstract][Full Text] [Related]
28. Testicular function of survivors of childhood cancer: a comparative study between ifosfamide- and cyclophosphamide-based regimens.
Ridola V; Fawaz O; Aubier F; Bergeron C; de Vathaire F; Pichon F; Orbach D; Gentet JC; Schmitt C; Dufour C; Oberlin O
Eur J Cancer; 2009 Mar; 45(5):814-8. PubMed ID: 19216070
[TBL] [Abstract][Full Text] [Related]
29. Ifosfamide in the treatment of ovarian cancer.
Markman M
Semin Oncol; 1996 Jun; 23(3 Suppl 6):47-9. PubMed ID: 8677449
[TBL] [Abstract][Full Text] [Related]
30. The role of ifosfamide in the treatment of testicular and urothelial malignancies.
Roth BJ
Semin Oncol; 1996 Jun; 23(3 Suppl 7):19-27. PubMed ID: 8711497
[TBL] [Abstract][Full Text] [Related]
31. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
Chang AY; Boros L; Garrow GC; Asbury RF; Hui L
Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
[TBL] [Abstract][Full Text] [Related]
32. Ifosfamide: new idications-new dose strength. Limited evidence of effectiveness.
Prescrire Int; 1998 Apr; 7(34):45-7. PubMed ID: 10183382
[TBL] [Abstract][Full Text] [Related]
33. Ifosfamide treatment of advanced ovarian cancer.
Yazigi R; Wild R; Madrid J; Arraztoa J
Obstet Gynecol; 1984 Feb; 63(2):163-6. PubMed ID: 6694809
[TBL] [Abstract][Full Text] [Related]
34. Ifosfamide neurotoxicity. A challenge for nurses, a potential nightmare for patients.
Cameron JC
Cancer Nurs; 1993 Feb; 16(1):40-6. PubMed ID: 8384523
[TBL] [Abstract][Full Text] [Related]
35. Ifosfamide in the treatment of small cell lung cancer.
Ettinger DS
Semin Oncol; 1996 Jun; 23(3 Suppl 6):2-6. PubMed ID: 8677443
[TBL] [Abstract][Full Text] [Related]
36. Paraplatin (carboplatin): new advances in cancer therapy. Update on clinical experiences. Proceedings of a satellite symposium. Madrid, Spain, 2 November 1987.
Cancer Treat Rev; 1988 Jun; 15 Suppl B():1-44. PubMed ID: 3042129
[No Abstract] [Full Text] [Related]
37. Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group.
Bramwell VH; Mouridsen HT; Santoro A; Blackledge G; Somers R; Verweij J; Dombernowsky P; Onsrud M; Thomas D; Sylvester R
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S180-4. PubMed ID: 8453694
[TBL] [Abstract][Full Text] [Related]
38. [Polymorphism at the glutathione S-transferase pi locus as a risk factor for ifosfamide nephrotoxicity in children].
Zielińska E; Zubowska M; Bodalski J
Pol Merkur Lekarski; 2003 Apr; 14(82):295-8. PubMed ID: 12868187
[TBL] [Abstract][Full Text] [Related]
39. Excretion kinetics of ifosfamide side-chain metabolites in children on continuous and short-term infusion.
Silies H; Blaschke G; Hohenlöchter B; Rossi R; Jürgens H; Boos J
Int J Clin Pharmacol Ther; 1998 May; 36(5):246-52. PubMed ID: 9629987
[TBL] [Abstract][Full Text] [Related]
40. Effect of ifosfamide treatment on glutathione and glutathione conjugation activity in patients with advanced cancers.
Mulders TM; Keizer ; Ouwerkerk J; van der Velde EA; Breimer DD; Mulder GJ
Clin Cancer Res; 1995 Dec; 1(12):1525-36. PubMed ID: 9815953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
